Login to Your Account



Acquisitions Continue

'Obvious' Buyout: Lilly Paying $2.1B For Cialis Partner ICOS

By Jennifer Boggs


Wednesday, October 18, 2006
ICOS Corp., which through a successful joint venture with Eli Lilly and Co. commercialized the erectile dysfunction product Cialis, agreed to be acquired by Lilly in a deal valued at about $2.1 billion. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription